The use of psychoactive medication in companion animals raises important welfare and ethical questions about when pharmaceutical intervention is appropriate and how to balance benefits against risks.
Anxiety medication in companion animals serves genuine welfare purposes when chronic anxiety causes ongoing suffering that behavior modification alone cannot adequately address. The ethical question is not whether to medicate but how to select, dose, and monitor medication appropriately to maximize welfare benefit while minimizing risk. Refusing to consider medication for a dog experiencing daily panic attacks because of philosophical objections to "drugging" animals is itself an ethically problematic position that prioritizes an abstract principle over concrete animal welfare. Medication decisions should be made collaboratively with veterinary behavioral expertise, with clear monitoring protocols and regular reassessment.